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Abstract
Background: Risky decision-making is commonly observed in persons at risk for and infected with HIV and is associated
with executive dysfunction. Yet it is currently unknown whether HIV alters brain processing of risk-taking decision-making.
Methods: This study examined the neural substrate of a risky decision-making task in 21 HIV seropositive (HIV+) and 19
seronegative (HIV-) comparison participants. Functional magnetic resonance imaging was conducted while participants
performed the risky-gains task, which involves choosing among safe (20 cents) and risky (40/80 cent win or loss) choices.
Linear mixed effects analyses examining group and decision type were conducted. Robust regressions were performed to
examine the relationship between nadir CD4 count and Kalichman sexual compulsivity and brain activation in the HIV+
group. The overlap between the task effects and robust regressions was explored.
Results: Although there were no serostatus effects in behavioral performance on the risky-gains task, HIV+ individuals
exhibited greater activation for risky choices in the basal ganglia, i.e. the caudate nucleus, but also in the anterior cingulate,
dorsolateral prefrontal cortex, and insula relative to the HIV- group. The HIV+ group also demonstrated reduced functional
responses to safe choices in the anterior cingulate and dorsolateral prefrontal cortex relative to the HIV- group. HIV+
individuals with higher nadir CD4 count and greater sexual compulsivity displayed lower differential responses to safe
versus risky choices in many of these regions.
Conclusions: This study demonstrated fronto-striatal loop dysfunction associated with HIV infection during risky decision-
making. Combined with similar between-group task behavior, this suggests an adaptive functional response in regions
critical to reward and behavioral control in the HIV+ group. HIV-infected individuals with higher CD4 nadirs demonstrated
activation patterns more similar to seronegative individuals. This suggests that the severity of past immunosuppression
(CD4 nadir) may exert a legacy effect on processing of risky choices in the HIV-infected brain.
Citation: Connolly CG, Bischoff-Grethe A, Jordan SJ, Woods SP, Ellis RJ, et al. (2014) Altered Functional Response to Risky Choice in HIV Infection. PLoS ONE 9(10):
e111583. doi:10.1371/journal.pone.0111583
Editor: Claire Thorne, UCL Institute of Child Health, University College London, United Kingdom
Received October 4, 2013; Accepted October 6, 2014; Published October 27, 2014
Copyright:  2014 Connolly et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Translational Methamphetamine AIDS Research Center (TMARC) is supported by Center award P50DA026306 from the National Institute on Drug
Abuse (NIDA). The funding agency played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and
preparation, review, or approval of the manuscript. The views expressed in this article are those of the authors and do not reflect the official policy or position of
the United States Government.
Competing Interests: The authors have declared that no competing interests exist.
* Email: agrethe@ucsd.edu (ABG); igrant@ucsd.edu (IG)
Introduction
The human immunodeficiency virus (HIV) can cross the blood-
brain barrier early in the course of infection and trigger a cascade
of functional and structural alterations [1,2]. One of the primary
loci of this damage is the deep grey matter of the basal ganglia [2]
which are reciprocally connected to a broad range of cortical
regions [3–5]. HIV infection has been reliably linked to injury of
the fronto-striato-thalamo-cortical loops [6], and can thus
adversely impact a variety of higher-order neurocognitive func-
tions that rely on these circuits. For example, HIV-associated
neurocognitive deficits have been observed in approximately half
of infected persons in such ability areas as fine-motor skills [2],
working memory [7], and executive function [8].
Risk-taking and reward processing are important processes that
influence behavior [9]. Making a choice in a risky situation
typically requires a choice between an option that is associated
with a large outcome that may be either advantageous or
disadvantageous versus an alternative with a smaller, more certain
advantageous outcome [10,11]. One formulation of risk is its
econometric definition as the variance of the value of the possible
outcomes [12]. This conception, however, does not account for the
influences of emotion since human decision-making is not always
rational [13]. More recent approaches attempt to bridge the gap
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between rational choice and emotions guiding decisions. For
example, the somatic marker hypothesis [14,15], affect heuristic
hypothesis [16] and risk-as-feelings hypothesis [17] posit that
emotions are integrated with cognitive evaluation of choices to
regulate the decision making process.
Risky decision-making is commonly observed in individuals at
risk for (e.g., [18]) and infected with (e.g., [19,20]) HIV. For
example, on the Iowa Gambling Task (IGT), HIV-infected (HIV+)
individuals made disproportionately more selections from ‘‘bad’’
decks as the task progresses (e.g., [19,20]), which may reflect poor
inhibition response to the lure of high rewards even in the face of
large penalties [20]. Such risky decision-making is more common
in individuals with HIV-associated Neurocognitive Disorders
(HAND; [21]) and has been specifically, but not consistently,
linked to cognitive inflexibility and engagement in HIV transmis-
sion risk behaviors (e.g., [22]). Additionally, personality charac-
teristics such as sensation seeking, that is a propensity to seek out
novel, exciting and arousing stimuli, have been associated with risk
behaviors for HIV infection [23,24]. However, few studies have
examined the neural substrates of risky decision-making in HIV.
A number of neuroimaging studies have shown that HIV
infection can alter brain function [25–33]. In functional magnetic
resonance imaging (fMRI) experiments, HIV+ individuals have
been shown to exhibit deficits on tests of attention and working
memory and altered responses within the associated neural
substrates [25–27,31,32]. In these tasks, HIV+ individuals
exhibited greater activation and/or larger load dependent
increases in the frontal and parietal cortical regions underlying
task performance [25–27,31], a pattern that is consistent with
damage to fronto-striatal white matter tracts that has been
attributed to HIV infection [34]. Preliminary evidence suggests
that hippocampal function can be affected by HIV infection [28].
Reduced hippocampal activation during encoding and elevated
hippocampal activation during the recall phase of a verbal
memory task having been reported in a sample of HIV+ women
[28]. There has been a recent interest in the use of magnetoen-
cephalography (MEG) in the study of HIV infection in part due to
its high test-retest reliability in HIV infection [35]. These studies
have reported strong responses (in the 8–13 Hz band) in the
dorsolateral prefrontal cortex (DLPFC) during a simple finger
tapping task [30]. Reduced levels of synchronization (in the 6–
12 Hz band), recorded during a simple visual processing task, have
been also been observed in a HIV+ compared to a control group
[29]. Furthermore, those HIV+ individual with desynchronization
more similar to controls demonstrated better performance on a
neuropsychological test of verbal learning [29]. Notably, cortical
thinning in the DLPFC has been linked to the severity of immune
suppression in HIV infection [36]. Finally, reduced functional
connectivity has been reported in resting state MEG [37] and in a
fMRI task studying semantic event sequencing [38]. Together,
neuroimaging studies showing preferential involvement of fronto-
basal ganglia brain systems in HIV-infection [25,33,38] and
neuropsychological studies of the maladaptive use of feedback in
risky choice [8,19,20,39] lay the foundation for fMRI studies to
more directly link impaired behavior with abnormalities of the
brain substrates of risky decision-making and reward in HIV
infection.
Extensive study of risk-taking in the context of decision-making
has revealed a key network of cortical and subcortical brain
regions. This network is composed of circuits, two of which,
namely the ventral limbic circuit and the dorsal executive circuit,
may be important to choice behavior. The ventral circuit includes
several striatal structures: the nucleus accumbens, rostromedial
caudate, rostroventral putamen, and ventromedial caudate [40].
These regions receive extensive innervation from prefrontal
cortical regions such as the orbitofrontal and ventromedial cortex
[41,42] and insula [40]. This circuit is implicated in the
identification of rewarding and emotionally salient stimuli,
integrating these with autonomic, visceral, and hedonic informa-
tion, and generating affective responses to these stimuli [43–48].
The dorsal executive circuit encompasses the dorsal caudate,
dorsal anterior cingulate cortex (DACC), and DLPFC. In this
circuit DACC is thought to play a role in performance monitoring
[49–53] whereas DLPFC is thought to be important to the
maintenance of goal-directed behavior [54,55]. Indeed, in the
context of risky-choice behavior, modulation of activity within the
DLPFC can lead to different response styles under risk [56–58].
The anterior cingulate cortex (ACC) and DLPFC are extensively
interconnected [59] with the DACC also projecting to the dorsal
caudate [40]. This circuit is important to selective attention,
planning and effortful regulation of affective states, including task
switching and inhibition. Acting in concert, these two circuits may
code stimulus-reward value, maintain representations of predicted
future reward and future behavioral choice, and transform
decisions into motor output, playing a role in integrating and
evaluating reward prediction to guide decisions.
This study aimed to examine whether HIV alters brain
processes underlying risk-taking decision-making. We hypothe-
sized that greater activity for risky choices would be observed in
grey matter basal ganglia regions. Additionally, we theorized that
dorsolateral and anterior cingulate cortex would display greater
activity in the HIV+ group relative to HIV- comparisons, and that
this may be an adaptive functional response to compensate for
aberrant information provided by other cortical and subcortical
structures that may have been impacted by HIV infection. Finally,
we explored whether nadir cluster of differentiation 4 (CD4) count,
a measure of historical immune function that has been shown to
predict neurocognitive impairment [60–64] and structural vol-
umes [65] in HIV+ individuals, would demonstrate any associa-
tion with functional brain measures of risky decision-making.
Materials and Methods
Ethics Statement
The University of California, San Diego human research
protection program approved this study. Participants gave
informed written consent and were compensated for their time
and effort.
Participants
Participants were recruited as part of the Translational
Methamphetamine AIDS Research Center and included 21
HIV+ and 19 seronegative comparison adults. HIV status was
confirmed by MedMira Multiplo rapid test (MedMira Inc., Nova
Scotia, Canada). All participants were seronegative for Hepatitis C
virus (HCV) as determined by the MedMira Multiplo rapid test.
Current CD4 T lymphocyte counts (cells/ml) were determined by
flow cytometry at a medical center laboratory certified by Clinical
Laboratory Improvement Amendments (CLIA), or CLIA equiv-
alent. HIV RNA levels were measured in plasma by reverse
transcriptase PCR (Roche Amplicor, v. 1.5, lower limit of
quantitation 50 copies/ml). CD4 nadir was obtained by self-
report, with confirmation by documented prior measurements in a
subset of individuals. Participants were excluded if they tested
positive for illicit drugs (with the exception of marijuana (MJ)) or
alcohol (urine toxicology screen or Breathalyzer respectively) on
the day of scan; had contra-indications for MRI; had a lifetime
history of schizophrenia or other primary psychotic disorders; had
Risky Choice in HIV Infection
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previous cerebrovascular events, determined by comprehensive
neurological exam; head injury with loss of consciousness for
greater than 30 minutes or resulting in neurologic complications;
seizure disorder; demyelinating diseases from non-HIV neurolog-
ical disorders; met Diagnostic and Statistical Manual of Mental
Disorders (4th Edition-Text Revision; DSM-IV-TR) [66] condi-
tions for substance (other than alcohol, MJ and nicotine) abuse in
the prior year or dependence within the preceding five years.
Participants who met criteria for lifetime dependence or abuse of
MJ within the last 12 months were enrolled. Those who met
lifetime criteria for alcohol abuse within the prior 12 months were
enrolled but were excluded if they met criteria for dependence
within the previous 12 months. Nicotine use was not exclusionary
and participants were told not to alter their typical pattern of daily
usage. They were asked to refrain from smoking during the break
in the scanning session. Breath carbon monoxide levels and the
presence of cotinine in urine were assessed on the day of the scan.
Participant Assessment
Assessment took place on two separate visits: an initial
neurological and neuropsychiatric visit and a subsequent MRI
scan (see Table 1 for the interval between visits). Determination of
relevant psychiatric diagnoses were achieved using the Composite
International Diagnostic Interview (CIDI 2.0) [67], a computer
based structured interview administered by a trained research
associate on the initial visit. This evaluation tool yields lifetime and
current (within 1 month) diagnoses that are consistent with DSM-
IV-TR [66] criteria. The resultant measures of mood and
substance use disorders were used to inform eligibility for study
enrollment and characterizing the sample. Additionally, partici-
pants were asked their age, gender, handedness, and sexual
orientation.
Since HIV has been associated with cognitive impairment [68],
all participants completed the oral word reading subtest of the
Wide Range Achievement Test (WRAT-4) [69] on the initial visit
and a comprehensive neuropsychological test battery (described in
detail in [70]), performance on which was summarized using the
Global Deficit Score (GDS) [68,71,72]. Specifically, we assessed
the following domains: speeded information processing, verbal
fluency, learning, working memory, executive functions, and
motor skills (more details can be found in [21]). As neuropsychi-
atric symptoms are common in many HIV+ individuals [73], we
also administered the Beck Depression Inventory-II (BDI-II) [74]
and Profile of Mood State (POMS) [75] on the day of the scan.
BDI-II was also measured on the initial visit. Deficits in the IGT
suggest that HIV+ individuals tend to choose larger immediate
rewards over smaller rewards that result in longer term gains
overall [19,20]. This suggests an impulsive response style in HIV+
individuals [19]. Consequently, we measured this using the Barratt
Impulsiveness Scale-11 (BIS-11) [76]. Furthermore, since risky
decision-making in HIV+ individuals may be related to sensation
seeking and could represent a common pathophysiology [22], we
chose to measure it using the Kalichman Sexual Sensation Seeking
Scale (KS4) [24] which assesses personality characteristics and
high-risk sexual behavior known to be associated with HIV
transmission risk [23,24]. Estimates of smoking rates among HIV-
infected individuals are in the range of 50–70% [77,78] with
smokers being less likely to adhere to antiretroviral medication
regimes [79]. We therefore assessed nicotine usage using the
Fagerstro¨m Test for Nicotine Dependence (FTND) [80].
Task
Participants were administered the risky-gains task as previously
described [81–83] and depicted in Figure 1. The task consists of
102 trials during which the numbers 20, 40, and 80 are presented
in ascending order for one second each. Our choice of numbers,
where each one is twice the preceding choice, was motivated by
the observation that people typically reject gambles unless the
amount that could be gained is at least twice the amount that
could be lost [84]. The serial nature of the task, which required
participants to make sequential fast judgments as to whether to
accept or reject the amount displayed on the screen, was designed
to capture the escalating tension that often accompanies natural-
istic risky decision-making [17]. If the participant made a button
press within one second of stimulus onset, that amount (20/40/80)
could be added to their total winnings along with immediate visual
and auditory feedback. When a 40 or 80 appear there is a chance
that it appears in a different color with immediate feedback
indicating the loss of 40- or 80-cents, respectively. When this
happens the trial ends immediately and the participant may not
make any more responses. Each of the 102 trials lasted 3.5s
regardless of the participants’ choices and whether punishment
was scheduled or not.
Participants were told that waiting for 40- or 80-cents was risky
as, though it was possible to win more, it was also possible to lose
that amount. Additionally, they were informed that though they
would win less if they chose 20-cents, there was no risk of loss
associated with this choice. That is, they could always win by
choosing a 20-cents. However, participants were not told that
there was no inherent advantage to choosing the risky (40, 80)
choices over the safe choices (20). While the best response for each
trial depended on whether there was a punishment scheduled for
that trail or not, a strategy of selecting all 20 s would yield exactly
the same winnings as selecting all 40 s or all 80 s.
Three different trial types were presented in a predetermined
pseudo-randomized order: (1) non-punished (20, 40, or 80; n= 54),
(2) punished 40 (n= 24), (3) punished 80 (n = 18) and six null trials.
The relative number of punished and non-punished trials was
chosen to guarantee that the strategy of consistently choosing 20-
cents or always selecting 40- or 80-cents would yield the exact
same winnings. Punishment occurred on a punished trial only if
the participant failed to respond to the previous numbers on that
trial (i.e. when holding out for 80 they did not respond to either the
20 or 40 stimulus). The relative frequency of safe (20) to risky (40
and 80) was used to quantify baseline risk-taking behavior. To
investigate the sensitivity to punishment, defined here as the
propensity to alter choice pattern on a trial immediately following
a losing trial, the relative frequency of risky responses was
examined as a function of the outcome of the previous trial, that is,
punished versus non-punished risky trials.
This task has previously been used to assess risk-taking behavior
in healthy volunteers [81]. This investigation revealed activation
differences in insula, DLPFC, and posterior parietal cortex.
Greater activation was observed in the insula during risky than
during safe choices. The insula also showed significant activation
on punished trials with activation magnitude predicting subse-
quent safe choices after a punished trial. In a purely behavioral
study of stimulant users [82], we observed greater propensity for
risk taking in the stimulant users but a similar degree of sensitivity
to punishment in both the users and a control group. Those with
higher measures of sensation seeking and impulsivity showed
greater propensity to risk taking. Finally, Lee et al. [83] examined
the effect of aging using the risky gains task. They reported greater
levels of risk taking in younger people and more safe choices in
older adults with faster reaction times to risky choices irrespective
of group. They also observed greater insula and DLPFC activation
for risky as compared to safe choices in the older adult group.
Risky Choice in HIV Infection
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Table 1. Characteristics of the HIV- and HIV+ groups.
Characteristic HIV- a HIV+ a DoF Statistic b P-value Effect Size c Significance
Demographic Characteristics
Number of Participants 19 21 1.00 x2= 0.03 0.87
Gender (M/F) 18/1 19/2 1.00 x2<0 1.00
Sexual Orientation (MSM/Heterosexual) 5/14 18/3 1.00 x2= 12.07 ,0.001 ***
Handedness (R/L) 18/1 18/3 1.00 x2= 0.18 0.67
Age at time of scanning (years) 38.162.5 (23–54) 40.862.6 (23–58) 37.99 t =20.74 0.46
Years of education 14.460.5 (11–20) 13.860.5 (9–18) 37.97 t = 0.85 0.40
Days between initial and scanning visits{ 58637.1 (19–124) 77644.5 (23–733) NA W=135.5 0.09 g = 0.34
Ethnicity (%) 3.00 x2= 3.85 0.28
African-American 2.5 12.5
Hispanic 12.5 10
Other 0 2.5
White 32.5 27.5
Scanner (n) 1.00 x2= 5.05 0.02
East 10 3
West 9 18
Dates of scan acquisition d
East 2011/02/03–
2011/08/10
2010/06/05–
2010/08/14
West 2011/04/01–
2012/04/04
2011/01/03–
2012/03/19
Psychiatric Characteristics
Wide Range Achievement Test 106.162.7 (94–134) 99.762.2 (85–134) 35.81 t = 1.85 0.07 g = 0.60
Global Deficit Score{ 0.260.2 (0–1) 0.360.3 (0–1.9) NA W=151.5 0.20 PS = 0.38
Global Deficit Score Impaired (n) 3 7 1.00 W= 0.84 0.36
Speeded Information Processing 51.861.9 (38.8–69.5) 48.161.9 (31.5–63.8) 37.95 t = 1.38 0.17 g = 0.40
Verbal Fluency 49.261.9 (38–66.7) 46.561.6 (35.3–64.7) 35.92 t = 1.10 0.28 g = 0.30
Learning 46.862.2 (20–58) 42.361.6 (24.5–56) 32.91 t = 1.63 0.11 g = 0.50
Working Memory 51.762.3 (28.5–68) 4761.5 (33.5–59.5) 31.28 t = 1.68 0.10 g = 0.50
Executive Functions 51.162.2 (34.5–67.8) 4662 (29.2–68.5) 37.07 t = 1.7 0.10 g = 0.50
Motor Skills 52.462.4 (38–71.5) 49.762.5 (33.5–72) 38.00 t = 0.78 0.44 g = 0.20
BDI-II (at initial visit) 1.760.6 (0–7) 10.962.2 (0–35) 22.53 t =24.07 0.00 g =21.3 ***
BDI-II (at time of scan) 1.760.8 (0–14) 8.662 (0–35) 25.71 t =23.16 ,0.01 g =21.00 **
POMS (at time of scan) 55.863.3 (25–78) 68.866.6 (27–146) 29.02 t =21.75 0.09 g =20.50
Lifetime MDD Diagnosis (n) 3 11 1.00 x2= 4.37 0.04 *
Current MDD Diagnosis (n) 0 5 1.00 x2= 3.22 0.07
Kalichman Sexual Sensation Seeking
Scale
Sexual Sensation Seeking Scaled (Mean) 1.860.1 (1.2–2.6) 2.160.1 (1–3.3) 34.04 t =21.79 0.08 g =20.60
Non Sexual Sensation Seeking
Scaled (Mean)
2.360.1 (1.5–3.5) 260.1 (1.3–3) 36.32 t = 2.02 0.05 g =20.60 *
Sexual Compulsivity Scaled (Mean) 1.160 (1–1.6) 1.460.1 (1–2.4) 26.01 t =22.33 0.03 g =20.70 *
Barratt Impulsiveness Scale
Total 59.362.3 (46–79) 61.162.4 (45–85) 38.00 t =20.54 0.59
Attentional Subscale 15.360.7 (9–20) 16.660.8 (9–22) 37.86 t =21.16 0.25
Motor Subscale 18.160.8 (13–30) 19.160.9 (13–27) 37.96 t =20.84 0.41
Non Planning Subscale 2661.2 (16–38) 25.561.1 (16–38) 37.05 t = 0.32 0.75
Clinical Characteristics
Duration of Infection (months) Not applicable 96.9622.8 (1.6–318.1)
Nadir CD4 Count{ Not applicable 2506174.9 (3–763)
Current CD4 Count{ Not applicable 4266277.2 (81–1061)
Risky Choice in HIV Infection
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MR Data Acquisition
Functional images were acquired in bottom-up interleaved axial
slices using T2* weighted echo planar imaging (EPI). Images were
acquired on two scanners: a 3T GE Discovery MR 750
(Milwaukee, WI) (252 volumes TR/TE=2 s/30 ms, flip an-
gle = 90u, 64664 matrix, 40 axial slices, 3.7563.7563.0 mm
voxels) and a 3T GE Signa HDx (Milwaukee, WI) (252 volumes,
TR/TE=2 s/30 ms, flip angle = 90u, 64664 matrix, 40 3.0 mm
(2.6 mm +0.3 mm gap) axial slices, 3.563.5 mm voxels). High-
resolution T1-weighted fast spoiled gradient echo anatomical
images (MR 750: TR/TE=8.1 ms/3.17 ms, flip angle = 8u,
2566256 matrix, 172 sagittal slices, 16161 mm voxels; Signa
HDx: TR/TE=7.77 ms/2.97 ms, flip angle = 8u, 2566256 ma-
trix, 172 sagittal slices, 0.9760.9761 mm voxels) were acquired to
permit subsequent activation localization and spatial normaliza-
tion. Gradient echo field-maps were also acquired to permit
compensation for geometric distortions caused by magnetic field
inhomogeneity (MR 750: TR=1 s, TE= 3.7/5.5 ms, flip an-
gle = 60u, 64664 matrix, 160 axial slices, 3.7563.7563 mm
voxels; Signa HDx: TR=1 s, TE=3.5/5.5 ms, flip angle = 60u,
64664 matrix, 160 3.0 mm (2.6 mm +0.3 mm gap) axial slices,
3.563.5 mm voxels). Stimuli were projected onto a screen at the
Table 1. Cont.
Characteristic HIV- a HIV+ a DoF Statistic b P-value Effect Size c Significance
Plasma Viral Load (% Detectable) Not applicable 42.90
AIDS (%) Not applicable 47.60
ART Currently Prescribed (%) Not applicable 71.43
ART Past Use (%) Not applicable 9.52
ART Never Used (%) Not applicable 19.05
Current Substance Use Characteristics
Fagerstro¨m Test for Nicotine
Dependence (Total Score)
1.660.6 (0–8) 1.860.6 (0–9) 38 t =20.22 0.82
Nicotine Dependence (%) 0 5 (23.8) 1 x2= 3.22 0.07
Alcohol Abuse (%) 1 (5.3) 0 1 x2<0 0.96
Alcohol Dependence 0 0
Cannabis Abuse 0 0
Cannabis Dependence 0 0
Lifetime Substance Use Characteristics
Alcohol Abuse (%) 5 (26.3) 5 (23.8) 1 x2<0 1
Alcohol Dependence (%) 2 (10.5) 1 (4.8) 1 x2= 0.01 0.93
Cannabis Abuse (%) 5 (26.3) 4 (19.0) 1 x2= 0.03 0.86
Cannabis Dependence (%) 0 1 (4.8) 1 x2<0 1
Cocaine Abuse 0 0
Cocaine Dependence 0 0
Methamphetamine Abuse 0 0
Methamphetamine Dependence 0 0
Hallucinogen Abuse (%) 1 (5.3) 0 1 x2<0 0.96
Hallucinogen Dependence (%) 0 1 (4.8) 1 x2<0 1
Inhalant Abuse 0 0
Inhalant Dependence 0 0
Opioid Abuse 0 0
Opioid Dependence 0 0
PCP Abuse 0 0
PCP Dependence 0 0
Sedative Abuse (%) 0 1 (4.8) 1 x2<0 1
Sedative Dependence 0 0
MDMA Abuse 0 0
MDMA Dependence (%) 0 1 (4.8) 1 x2<0 1
aMean 6 SEM (min - max) or median 6 MAD (min - max) if indicated by {.
bStatistic: W, Wilcox rank sum test; x2, x2 test for equality of proportions; t, Student’s T test.
cEffect size: g, Hedge’s g; PS, probability of superiority.
dDates are in year/month/day format.
Abbreviations: SEM, standard error of the mean; MAD, median absolute deviation; MSM, men who have sex with men; BDI-II, Beck Depression Inventory II, POMS, Profile
of Mood States; MDD, Major Depressive Disorder; CD4, Cluster of Differentiation 4; AIDS, Acquired Immunodeficiency Syndrome; ART, Anti-retroviral therapy; MDMA,
3,4-methylenedioxymethylamphetamine; DoF, degrees of freedom; NA, not applicable; M, male; F, female; R, right; L, left. ’*’ p,0.05, ’**’ p,0.01.
doi:10.1371/journal.pone.0111583.t001
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participants’ feet and viewed with the aid of a mirror attached to
the head coil.
MR Data Analysis
Analyses were conducted using AFNI [85] and FSL [86]. T1-
weighted images were skull-stripped using 3dSkullStrip and
transformed to MNI152 standard space using FLIRT [87,88]
followed by nonlinear registration using FNIRT [89,90]. Func-
tional images were processed using FUGUE to compensate for B0
inhomogeneity [91]. Time series were motion corrected using an
iterated linearized weighted least squares algorithm and aligned to
the anatomical using a local Pearson correlation method [92]
before being subjected to global mean-based intensity normaliza-
tion. These were resampled to 3 mm isotropic voxels and
transformed to standard space using the warp fields derived from
transforming the T1 anatomy to MNI152 space. Finally, the time
series were spatially blurred with a 4.2 mm isotropic FWHM
Gaussian filter kernel within a mask derived from the T1 anatomy.
Data were visually inspected to assess the quality of the warping
and alignment. Preprocessed time series were subjected to multiple
linear regression. Time series of interest, derived from the
behavioral data (described below), were convolved with a gamma
variate function [93] and subsequently normalized to a peak
amplitude of 1.
Decision phase regressors were created such that they started at
trial onset and ended either when the participant responded or was
punished. Five regressors were defined: (1) 20 (safe), (2) win 40, (3)
win 80, (4) lose 40, and (5) lose 80. General linear tests (GLT) of
the safe (20) versus the risky win (40, 80) choices were computed
for each participant. The baseline comprised all other time-points
not accounted for by the regressors of interest. Additionally, six
nuisance motion-related regressors (three translational and three
rotational) and a 3rd order Lagrange polynomial, which accounted
for slow signal drift, were included in the baseline. Brain activation
was operationally defined as percent signal change relative to
baseline.
Task Related Group Analyses. The within-participant
general linear tests of safe versus risky choices were subjected to
linear mixed effects (LME) analyses in the R statistical analysis
package [94]. As some participants had a lifetime diagnosis of
major depressive disorder (MDD), a within-participant dichoto-
mous variable indicating the presence/absence of MDD was also
included in the model. Significant voxels were required to pass a
voxel-wise statistical threshold (F(1, 37) = 4.11, p = 0.05, uncorrect-
ed) and, to control for multiple comparisons, were required to be
part of a cluster of no less than 1685 mL. The volume threshold
was determined by a Monte-Carlo simulation that together with
the voxel-wise threshold resulted in a 5% probability of a cluster
surviving due to chance. The average percent signal change was
extracted from the clusters so formed and a series of post hoc t-
tests were conducted in R to examine the group and task
interaction effects.
Since the HIV+ group consisted of more nicotine users than the
HIV- group (see below), we conducted an additional analysis to
investigate whether there was an effect of nicotine usage (FTND
total score) on differential brain activation to risky versus safe
choices. This was performed within the HIV+ group and
accomplished using linear mixed effects models on the average
contrast of risky versus safe choices in each of the clusters identified
by the task related group analysis. In this analysis participant was
treated as a random effect.
Controlling for Scanner Effects. Several recent studies
have examined the effect of including MR data from multiple sites
within the same analysis. Overall, these studies reported that inter-
participant variance was anywhere from 7–44 times greater than
that generated by site variance [95–98], even when group
membership was confounded by site [99]. This suggests that
scanner-induced variance is less likely to contribute to task or
group-related effects. The inclusion of data from two scanners in
our study effectively makes it a multi-site study and though the
inclusion of site as a fixed-effect in the model examining group
differences has been recommended [100], our study data was
acquired in such a way that each participant was scanned only
once on one scanner. It was therefore not possible to separately
estimate the effects due to scanner and participant. Since scanner
and participant are confounded in our study, we opted to include a
dichotomous variable for scanner as the random effect in the linear
mixed effects model described above.
Figure 1. An illustration of four different trial types from the risky gains task: (A) lose 80, (B) win 20, (C) win 40 and (D) lose 40. The
blue arrow indicates participant response to select the value on screen.
doi:10.1371/journal.pone.0111583.g001
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Neuropsychiatric and Neuromedical Measures and Task-
Related Brain Activations. Whole-brain voxel-wise Huber
robust regressions [101,102] were conducted in R [94] to examine
the relationships between the neuromedical and neuropsychiatric
measures and GLTs of safe versus risky win trials in the HIV+
group. We opted to perform regressions as some of the
neuropsychiatric variables were confounded by diagnosis, and
the neuromedical variable existed solely within the HIV+ group,
precluding inclusion in the LMEs. Regressions were performed for
the non-sexual sensation seeking and sexual compulsivity subscales
of the KS4 based on our observation of between group differences
on these measures (see below). A further regression examining the
effect of nadir CD4 count was also conducted. Dichotomous
variables for lifetime MDD diagnosis and scanner (for reasons
outlined above) were included in these models. In the case of the
nadir CD4 count, age and estimated duration of infection were
also included in the model, as older participants or those with
longer durations of HIV infection might have had lower nadirs
and accumulated more damage due to HIV infection [103] that
may manifest in altered brain functioning.
In all cases, regression coefficients and their corresponding t-
values were split according to whether they demonstrated a
positive or negative relationship with the GLTs. Thereafter,
significant voxels were required to pass a voxel-wise statistical
threshold (t(18) = 2.10, p = 0.05, uncorrected) and, to control for
multiple comparisons, were required to be part of a cluster of no
less than 1685 mL which resulted in a 5% chance of a cluster
surviving due to chance. The volume threshold was determined in
the same manner as above.
Overlap between Group and Regression Regions of
Interest. To investigate whether between-group differences
could potentially be attributed to neuropsychiatric and neurome-
dical variables, we assessed whether the regions identified from the
task related analysis overlapped with those regions identified by
the robust regression analysis. To accomplish this we computed
the intersection of all those regions from the task related analysis
with those from the regression analyses conducted solely within the
HIV+ group. Since both of the maps included in this analysis
included significantly different clusters, the resultant overlap maps
can, therefore, also be regarded as statistically significantly
different [104].
Demographic and Clinical Scales Analysis
All analyses were conducted in R [94]. Between-group
differences for demographics and clinical scales were assessed by
means of Welch T tests for age, years of education, WRAT-4,
BDI-II, POMS, KS4, BIS-11, FTND, speeded information
processing, verbal fluency, learning, working memory, executive
functions, and motor skills. Effect sizes were computed using
Hedge’s g [105]. A linear mixed effects analysis (where participant
was treated as a random effect) was conducted to investigate
whether there was an effect on the BDI-II score of group, visit
(baseline, scanning day), and their interaction. Group differences
in GDS and days between the initial visit and scanning were
assessed using Wilcox rank sum test. Effect sizes for these two
measures were computed using the probability of superiority
[106]. Group differences in gender, ethnicity, handedness, sexual
orientation, the number of participants per group, the number of
participants per scanner, and the number of individuals with a
positive urine toxicology test for MJ were assessed using x2 test of
equal proportions. Using Spearman’s rank correlation test, we
tested for the presence of a relationship between BDI-II score and
the mean percentage signal change from each of the clusters
resulting from the task-based whole brain analysis. This correla-
tion was performed both solely within participants with lifetime
diagnosis of MDD and within the sample as a whole.
Task Analysis
The behavioral data gathered during task performance was
subjected to a 3-way ANOVA in R [94]. In this model the effect of
response choice (2 levels: safe (20) and risky (40, 80)), group (2
levels: HIV- and HIV+), punishment (2 levels: non-punished and
punished trial), and their interactions were examined. This
permitted assessment of the effects of choice behavior and
susceptibility to prior punishment and how these varied by group.
Results
Demographics
There were no significant differences between the serostatus
groups in age (t(37.99) =20.74, p.0.1), handedness (x2(1) = 0.18,
p.0.1), gender (x2(1) = 1.00, p.0.1), years of education
(t(37.97) =20.85, p.0.1), or ethnicity (x2(3) = 3.85, p.0.1). The
groups differed in terms of sexual orientation, with the HIV+
group composed primarily of men who have sex with men,
whereas the HIV- group was predominantly heterosexual
(x2(1) = 13.81, p,0.001). Three participants tested positive for
MJ (2 HIV+, 1 HIV-), a proportion that did not differ between
groups (x2(1)<0, p<1). None of these participants met DSM-IV
criteria for current or lifetime substance abuse or dependence. No
participants tested positive for alcohol.
Clinical Scales
There was no difference between the groups on GDS
(W=151.50, p.0.05). Three HIV- and seven HIV+ were classed
as impaired (GDS .0.5); the proportions did not differ between
the two groups (x2(1) = 0.84, p.0.1). There were no between-
group differences observed in any of the speeded information
processing, verbal fluency, learning, working memory, executive
functions, and motor skills domains (all p$0.1). There was a trend
for the HIV- group to exhibit a higher WRAT-4 score than the
HIV+ group (t(35.81) = 1.85, p = 0.07, g = 0.60). On the subscales
of the KS4, the groups did not differ on the sexual sensation
seeking subscale (t(34.04) =21.79, p.0.05, g =20.60) but the
HIV-positives scored higher on sexual compulsivity (t(26.01) =
22.33, p,0.05, g =20.70) and lower on non-sexual sensation
seeking (t(36.32) = 2.02, p,0.05, g = 0.60). The groups showed no
differences on the BIS-11 or any of its subscales (all p.0.05) (See
Table 1.) Three HIV- and 11 HIV+ participants had a lifetime
diagnosis of MDD (x2(1) = 4.37, p,0.05). The HIV+ group was
comprised of marginally more nicotine dependent individuals than
the HIV- group (x2(1) = 3.22, p = 0.07). There were no significant
between-group differences on nicotine usage measured by the
FTND (t(38) =20.22, p.0.1). There were no significant differ-
ences between the two groups on other substance use character-
istics (see Table 1). Significant between-group differences were
observed on the BDI-II scale with the HIV+ group endorsing
significantly greater levels of depression than the HIV- group both
at the initial visit (t(22.53) =24.07, p,0.001, g =21.3) and at the
time of scanning (t(25.71) =23.16, p,0.01, g =21.00). When
determining the stability of BDI-II score over time, the HIV+
group had significantly higher BDI-II scores than the HIV- group
(F(1, 38) = 14.06, p,0.001), there was no effect of visit (F(1, 38) =
1.81, p= 0.18), or an interaction between group and visit (F(1, 38) =
1.79, p = 0.18). This suggests that the BDI-II score was stable over
time. Finally, no significant between-group differences on the
POMS were observed (t(29.02) =21.75, p.0.05).
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Behavioral Task Results
A significant main effect of risk was evident (F(1, 214) = 337.92,
p,0.0001) with safe (M=0.65) responses more likely than risky
(M=0.16). No significant effects of punishment (F(1, 214) = 0.05,
p.0.05, punished: M=0.33, non-punished: M=0.33) or group
(F(1, 214) = 0.21, p.0.05; HIV-: M=0.33, HIV+: M=0.32) were
observed. No significant interactions of punishment 6 group
(F(1,214) = 0.06, p.0.05) or risk 6 punishment 6 group
(F(1,215) = 0.00, p.0.05) were observed. A marginally significant
effect for risk6group (F(1, 214) = 3.09, p = 0.08) was observed with
the HIV- group selecting risky choices marginally more than the
HIV+ group (HIV-: risky M=0.19, safe M=0.62; HIV+: risky
M=0.14, safe = 0.68). Consistent with our prior observations on
this task [81,82], a significant interaction of risk 6 punishment
(F(1,214) = 11.42, p,0.001) was observed wherein participants were
more likely to chose the safe option when the prior trial was
punished. See Table S2 for a complete list of the cell and marginal
means.
fMRI Task Results
Task Related Brain Activation. We identified eight regions
where the HIV- and HIV+ groups differed (Table 2 and Figure 2).
Cortical regions were located in the right anterior cingulate gyrus,
inferior parietal lobule, superior frontal gyrus, and bilaterally in
the middle frontal gyri. Two subcortical regions, one in each
hemisphere with centers of mass in the left lentiform nucleus and
right claustrum were identified. The left cluster extended dorsally
from the ventral striatum to include portions of the head and body
of the caudate and further extended to include parts of the
putamen and anterior insula. The right cluster predominantly
included portions of the head of the caudate and extended laterally
to include the anterior insula. An additional subcortical cluster in
the left thalamus was identified. Post hoc analyses were conducted
to identify the directionality of these effects. Within the HIV+
group, activation was greater for risky relative to safe choices in the
right ACC (t(31.31) = 4.56, p,0.001), left middle frontal gyrus
(t(28.43) = 4.97, p,0.001), right middle frontal gyrus
(t(27.86) = 6.39, p,0.001), left thalamus t(36.07) = 3.67, p,
0.001), right claustrum (t(26.66) = 4.58, p,0001), and right
superior frontal gyrus (t(28.76) = 3.21, p,0.001. Within the
HIV- group, there were no significant differences between risky
and safe choices (all p.0.1). For risky choices, the HIV+ group
displayed greater activation than the HIV- group in left thalamus
(t(70.83) = 2.66, p,0.01), left lentiform nucleus (t(68.71) = 3.41,
p,0.01), and right claustrum (t(57.64) = 2.37, p,0.05). For safe
choices, the HIV+ group displayed less activation than the HIV-
group in the right ACC (t(32.45) =24.1, p,0.001), left middle
frontal gyrus (t(30.58) =22.75, p,0.01), and right middle frontal
gyrus (t(36.48) =23.23, p,0.01). Within the participants with a
lifetime diagnosis of MDD, none of these clusters showed a
relationship with the BDI-II scores (all p.0.05). Across the sample
as a whole, none of the clusters showed a relationship with the
BDI-II scores (all p.0.05). Within the HIV+ group, there was no
relationship between nicotine usage (FTND total score) and the
contrast of risky versus safe choices in any of the aforementioned
brain regions (all p.0.1).
Neuromedical and Neuropsychiatric Measures and Task-
Related Brain Activations. Significant associations, detailed in
Table S1, between differential brain responses to risky versus safe
choice were identified for nadir CD4 and the Kalichman sexual
compulsivity subscale. Those individuals with a higher CD4 nadirs
exhibited lower activation in several regions including anterior
cingulate gyrus, bilateral inferior parietal lobules, and middle
frontal gyrus. Moreover, those individuals with higher ratings on
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the sexual compulsivity subscale of the KS4 showed lower
activation in cingulate gyrus, and medial and middle frontal gyri.
One region in the right pyramis was negatively associated with the
non-sexual sensation seeking subscale of the KS4.
Overlap between Group and Regression Regions of
Interest. Several brain regions identified as showing task-
related between-group differences overlapped with the regions
identified in the regression analysis results just described. Regions
that demonstrated a negative association with nadir CD4
overlapped with the between-group results in the right anterior
cingulate, bilateral middle frontal gyri, left inferior parietal lobule,
and right superior frontal gyrus. When the beta values for the risky
and safe choices that contributed to this negative relationship were
separated out, the difference between the two choice types
appeared to be driven almost entirely by an increased response
to the safe choice with greater nadir CD4 count (Figure 3).
Regions showing a negative relationship with the sexual
compulsivity subscale of the KS4 overlapped with the task related
clusters in the right anterior cingulate gyrus, left thalamus, and
right superior frontal gyrus. Similarly, when the risky and safe beta
values were separated out, the negative relationship appeared to
be largely driven by the relationship between safe beta values and
the compulsivity measure (Figure 4). No overlap between the non-
Figure 2. Brain regions identified by the between-group whole-brain analysis of the general linear test of risky (40, 80) versus safe
(20) choices. The bar charts indicate percentage signal change and are the breakdown of responses within group and by choice (20, 40, 80) in these
regions. Error bars indicate the standard error of the mean. L, left; R, right.
doi:10.1371/journal.pone.0111583.g002
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sexual sensation seeking subscale of the KS4 and the between-
group differences was observed.
Discussion
Risky decision-making is a common feature of HIV-associated
neurocognitive disorders, but its neural substrates within persons
living with HIV are poorly understood. Here, we examined risky
choice behavior in HIV+ individuals compared to seronegative
individuals using functional magnetic resonance imaging. We
observed significant between-group functional activation differ-
ences in a number of regions (ACC, DLPFC, caudate, and insula)
critical to risk and reward processing despite broadly similar task
performance between the two groups. In the overlap between the
task-related regions of interest and those resulting from the robust
regression analysis, those HIV+ individuals with greater sexual
compulsivity measured by the KS4 and higher nadir CD4 count
displayed lower differential responses to safe versus risky choices in
many of the regions that showed between-group task related
differences. Taken together, these results support the hypothesis
that HIV alters risk-related processing in the basal ganglia, among
other structures.
We observed significant between-group differences in left and
right hemisphere clusters that included subcortical regions and
small insular components. The subcortical constituents of this
cluster included the ventral and dorsal striatum. These regions
have been heavily implicated in reward related processing [47]. In
non-human primates, single unit recordings have revealed
populations of neurons in the caudate and putamen that fire in
proportion to the value of an action irrespective of whether the
action was subsequently executed [107,108]. In humans, fMRI
studies have shown that the ventral striatum is important to
judging reward value [109,110] and reduced striatal volume has
been reported in HIV infection [111]. Similarly, increased blood
oxygenation level dependent (BOLD) responses have been
recorded in the dorsal striatum in response to anticipation of
both primary (e.g., food) [112] and secondary (e.g., money) [109]
rewards. Additionally, BOLD responses in the dorsal striatum
have been shown to predict expected value of actual choices in a
risky context [113]. This has lead some to suggest that the striatum
is primarily involved in the prediction of reward value and that
other brain regions (e.g., the insula) may be more important to
quantifying risk [81,114,115]. The insula is thought to be
important to integrating autonomic, visceral, and hedonic
information [48], and it has been suggested that it is a critical
neural substrate for selecting between internally and externally
available homeostatically relevant information that serves to guide
behavior [48]. Indeed, greater activation levels within the insula
Figure 3. Within the HIV+ group, graphs of the relationship between nadir CD4 count and a subset of the voxels in each of the
clusters depicted in Figure 2 and Table 2. The subset of voxels is the overlap between the clusters showing between-group task related
functional differences and those clusters identified by the robust regression analysis conducted only within the HIV+ group. The black line is the
robust regression line on the difference between risky and safe responses. The red and blue lines are robust regression lines of the safe and risky
components of the black line. L, left; R, right; Inf, Inferior; Sup, Superior; Gy, Gyrus.
doi:10.1371/journal.pone.0111583.g003
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have be associated with risky choices in the task deployed here
[81,83]. Our results suggest that the differences in these clusters
are predominantly driven by the HIV+ group who display
progressively greater responses to the 20-, 40- and 80-cent choices
compared to the HIV- group. Larger striatal activation for high
gain/high risk trials has been observed in a study of decision
making under risk [116]. Our observation of increased activation
with greater value of the potential gain may be significant insofar
as it may be the functional neuroanatomical realization of over-
valuation of the potential benefit of risky choices which has
previously been reported in HIV+ individuals [19]. Alternatively,
it is possible that increasing activation to progressively higher
valued risky choices in these subcortical clusters may be related to
damage caused to the basal ganglia by HIV [2] and may thus be
an adaptive functional response to this injury [25]. Disambigua-
tion of these alternatives will require future studies.
There were significant between-group differences in activation
level in the right anterior cingulate between the HIV+ and HIV-
groups. This dorsal region of the ACC is thought to be important
to cognitive processes [117], reward-based learning and affective
valence [118,119]. Indeed, prior studies have indicated that the
ACC is critical to judging the magnitude and likelihood of risky
outcomes [120,121], and others have suggested that ACC
activation may be related to encoding of action cost [122] and
action selection for uncertain rewards [123]. It has also been
suggested that the ACC may perform a cost benefit analysis to
guide action selection [124]. Activation of the ACC in a risky
decision making paradigm has been associated with risk-aversive
behavior, whereas deactivation was correlated with risk-seeking
behavior [125]. Finally, the DACC has been proposed to play a
critical role in the detection of response conflict [55]. In the
context of decision making, tension between reward seeking and
loss avoidance may naturally give rise to a state of conflict [126].
The greater DACC activation for the risky choices in the HIV+
group may indicate that they are more sensitive to conflict
between risk seeking and loss avoidance behavior or, alternatively,
the cost of losing. Here, it may be the case for the HIV+ group that
the possibility of losing on the risky options outweighs that benefit
of winning. The opposite may be the case for the HIV- group: the
cost of losing on the risky choices may not loom large and be
reflected in the lower activation for the risky choices. This stands
in contrast to the observations on the IGT where HIV+ individual
make more selections from disadvantageous decks [19,20].
However, recent evidence suggests that this effect may be more
common in individuals with HAND [21]. The small number of
participants (n = 7) with HAND in the present study precluded
examination of this possibility here. Therefore, further studies with
larger numbers of participants with and without HAND are
required to assess whether the present patterns of activation would
vary by diagnosis.
Finally, consistent with prior finding of this task in [83], a
between-group activation emerged bilaterally in the middle frontal
gyrus, a component of the DLPFC. DLPFC is thought to be one of
the seats of higher executive brain function [127], and it has been
suggested that DLPFC plays a key role in the maintenance of goal-
directed behavior necessary for successful task performance when
alerted to the presence of conflicting behavioral choices by the
DACC [55]. Several studies have examined the role played by the
Figure 4. Within the HIV+ group, graphs of the relationship between Kalichman Sexual Compulsivity Scaled Mean and a subset of
the voxels in three of the clusters depicted in Figure 2 and Table 2. The subset of voxels is the overlap between the clusters showing
between-group task related functional differences and those clusters identified by the robust regression analysis conducted only within the HIV+
group. The black line is the robust regression line on the difference between risky and safe responses. The red and blue lines are robust regression
lines of the safe and risky components of the black line. L, left; R, right; Sup, Superior; Gy, Gyrus.
doi:10.1371/journal.pone.0111583.g004
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DLPFC during risky decision-making. In an fMRI study,
activation of the DLPFC has been identified in decision making
under uncertainty [126]. Using repetitive transcranial magnetic
stimulation, a technique that can transiently suppress neuronal
function [128], it has been shown that interrupting activity in the
right DLPFC can increase risk-taking behavior [57,58]. Another
technique, transcranial direct current stimulation, has also been
employed to assess the role of DPLFC in risky decision-making. In
this method, low-voltage direct current is passed through the brain
using electrodes placed on the scalp [129]. Using this technique, it
has been shown that increasing excitability of the right or left
DLPFC leads to risk-aversion and suggests that DLPFC may be
critical to the suppression of riskier choices [56].
DACC and DLPFC are extensively interconnected [59] and are
components of a dorsal executive circuit that is critical to
performance monitoring [49–53] and maintenance of goal-
directed behavior [54,55]. Furthermore, this dorsal circuit
interacts with the ventral circuit (consisting of insular and striatal
regions) to predict stimulus-reward value and guide future
behavior. The striatal regions of this circuit are known to be
injured by the HIV virus [2], and documented cognitive deficits in
HIV infection are consistent with fronto-striatal white matter
damage that has been attributed to HIV infection [34]. Our
observation of increased DACC and DLPFC activation in the
HIV+ group in the presence of broadly similar task performance
may therefore be an adaptive functional response [25,30] wherein
additional cortical resources are recruited to maintain task goals
[130]. This may be necessitated by aberrant information provided
by other cortical and subcortical structures to which the dorsal
circuit is connected and that may have been damaged by HIV
infection. Indeed, additional functional recruitment in the
presence of equivalent task performance has previously been
observed in HIV+ individuals performing visual attention tasks
[26,27,31,32], working memory tasks [25,26], and a simple finger
tapping task [30]. This has led some to suggest that functional
brain differences, in the absence of behavioral changes, may
precede clinical signs of cognitive impairment [25,38].
Since, relative to the seronegative group, the HIV+ group
displayed elevated sexual compulsivity – a factor that has been
associated with risk of HIV infection [131] – we investigated
whether sexual compulsivity would show any relationship between
differential activation to safe versus risky choices in the HIV+
group. Of those regions-of-interest (ROIs) identified as showing
between-group task related differences, a subset of voxels in three
of those ROIs (see Table 3) also showed a relationship with sexual
compulsivity. We separated out the risky and safe components of
this relationship. The change in differential responses to risky
versus safe responses appeared to be driven by an overall increase
in activation to both risky and safe choices with increasing
compulsivity (see Figure 4). While there are, to our knowledge,
currently no brain imaging studies that examine the relationship
between functional activation and sexual compulsivity, neurobio-
logical models of obsessive-compulsive disorder, however, have
implicated excessive activity in fronto-striatal circuits, particularly
in orbitofrontal, ACC, thalamus and caudate [132–136]. This
suggests that those HIV+ individuals with elevated sexual
compulsivity may be characterized by on overall increase of
activation in fronto-striatal regions.
Within the HIV+ group, we also investigated whether nadir
CD4 counts would show any relationship to differential activation
to safe versus risky choices. We observed that subsets of the voxels
identified as showing between-group task related differences also
showed a relationship to nadir CD4 count. As depicted in Table 3
and Figure 3, greater nadir CD4 counts were negatively associated
with decreased differences in response to risky versus safe choices
in all of the task related ROIs. When the risky and safe
components of this difference were separated out, the disparity
between risky and safe responses appeared to be driven by
increased activation to safe responses with greater nadir CD4
count. This suggests that differential activity to safe versus risky
choices may be, in part, predicted by nadir CD4 count.
Furthermore, it may be the case that those individuals with higher
nadir CD4 counts may have activations patterns more similar to
that of seronegative individuals than those with lower CD4 nadirs.
Table 3. Overlap between regions showing task related between-group differences (from Table 2) and regions identified by
robust regression relating brain activity to neuromedical and neuropsychiatric measures.
Structure Hemisphere BA Volume Average Average
(mL) t-valuea b value
Term: Nadir CD4 Polarity: Negative
Anterior Cingulate R 24/32 1,215 22.37 20.0011
Middle Frontal Gyrus L 9 216 22.89 20.0009
Middle Frontal Gyrus R 9/46 621 22.57 20.0011
Thalamus L 756 22.71 20.0024
Lentiform Nucleus L 13 108 22.84 20.0012
Claustrum R 378 21.52 20.0006
Inferior Parietal Lobule L 40 594 22.21 20.0013
Superior Frontal Gyrus R 10 486 22.39 20.0011
Term: Kalichman Sexual Compulsivity Scale Polarity: Negative
Anterior Cingulate R 24/32 3,456 22.61 20.42
Thalamus L 81 22.42 20.61
Superior Frontal Gyrus R 10 783 22.64 20.51
Term refers to the neuropsychiatric or neuromedical explanatory variable in the regression model from which the clusters were derived. Polarity refers to the sign
(positive or negative) of the regression coefficients from which the cluster was generated. BA, Brodmann Area; L, Left; R, Right. a t(17).
doi:10.1371/journal.pone.0111583.t003
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This finding is consistent with the so-called ‘‘legacy events’’
hypothesis wherein historical immune-compromise increases the
vulnerability of HIV-associated central nervous system injury
[30,36,61,65,103].
This study has several limitations. The data were acquired from
the two groups of participants on two different scanners. Though
we attempted to minimize the differences between the protocols on
both scanners and to account for this source of variation in our
models, future studies are required to replicate the results reported
here in the absence of this potential confound. This is a cross-
sectional study, and thus we cannot address whether the
differences reported here arose as a consequence of HIV infection
or whether they predated HIV infection. Future longitudinal
studies are required to determine whether factors such as duration
of infection or the use of anti-retroviral therapy may influence
impairment. In light of the recent report that risky decision-
making is more prevalent in individuals with HAND [21], future
studies should examine whether the effects reported herein are
driven by more impaired individuals. HIV infection has been
associated with risky decision making in individuals at risk for [18]
and infected with HIV [19,20]. Our observation in the behavioral
analysis of a marginally significant interaction of risk and group
with HIV- participants, counter-intuitively, choosing more risky
options than the HIV+ group therefore warrants further
investigation in a larger sample where the source of this
observation may be more fully explored. Recent studies have
reported differences in brain structure and function between
homosexual and heterosexual men [137,138]. The confounding of
the serostatus groups by sexual orientation in the present sample
prevented us from investigating whether HIV-infection status
interacts with sexual orientation in risky decision-making. Future
studies with a larger non-confounded sample are required to
elucidate this issue. Depression is common in many HIV+
individuals [73] and inclusion of such individuals arguably makes
the present sample more representative of the individuals seen in
clinics and thus improves the generalizability of our results.
Nevertheless, future studies should be conducted in groups with
equivalent levels of depression to determine the specificity of the
results reported herein. Risk for HIV infection has been associated
with substance use (cf. [139–142]) and, as with depression, our
inclusion of participants with histories of such behaviors arguably
makes our sample more representative of the HIV-infected
population. Nevertheless, substance use has been independently
associated with functional brain changes in many of the brain
regions reported here (e.g., [82,143–146]). Investigating the
specificity of the changes reported here in larger samples of
HIV+ individuals with and without a history of substance use is
therefore crucial. Given the preliminary evidence which suggests
that anti-retroviral therapy (ART) can effect recovery of brain
function to patterns typical of healthy controls [147], it remains
unclear whether ART can influence risky choice behavior or the
brain processes underlying it. Since our study was underpowered
to examine this question, future studies with larger cohorts are
required to examine this issue. Our sample of participants is
almost exclusively male, limiting generalizability to the female
population. Future studies with a larger sample of females are
required to address this issue. Finally, our study concentrated on
the time period prior to choosing between risky and safe options,
future studies should investigate whether HIV+ individuals,
compared to seronegative individuals, exhibit differences in
sensitivity to the outcomes of these choices.
Conclusions
In summary, the present study examined the functional
neuroanatomy of risky decision-making in HIV+ individuals
compared to seronegetative individuals. The HIV+ group
displayed altered functional responses to safe and risky choices
in several brain regions compared to the seronegetative group.
Specifically, these regions included portions of the anterior
cingulate, ventral and dorsal striatum, insula, and bilateral
DLPFC. These results are consistent with and further support
the role of these structures in risky decision-making [47,48,56–
58,148,149]. We observed greater DACC and DLPFC activation
to risky choices in the HIV+ group in the presence of broadly
similar task performance between the two serostatus groups. This
suggests an adaptive functional response [25], wherein additional
cortical resources are recruited to maintain task goals [130]. This
may be in response to aberrant information provided by other
cortical and subcortical structures to which these regions are
connected and that may have been damaged by HIV infection.
Within the HIV+ group, we observed increased activation in the
right ACC, left thalamus, and right superior frontal gyrus as a
function of increased sexual compulsivity. This suggests that those
HIV+ individuals with elevated sexual compulsivity may be
characterized by on overall increase of activation in fronto-striatal
regions. Finally, we also observed that greater nadir CD4 count
was significantly associated with greater activation to safe choices
rather than risky options in all of the regions displaying between-
group task-related differences. This suggests that HIV infection
may alter risk-related neural processing.
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